NMC
NEA Management Company’s X4 Pharmaceuticals XFOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $949K | Sell |
499,559
-14,487,234
| -97% | -$27.5M | 0.07% | 30 |
|
|
2025
Q1 | $3.54M | Hold |
14,986,793
| – | – | 0.27% | 29 |
|
|
2024
Q4 | $11M | Hold |
14,986,793
| – | – | 0.62% | 22 |
|
|
2024
Q3 | $10M | Hold |
14,986,793
| – | – | 0.55% | 28 |
|
|
2024
Q2 | $8.69M | Hold |
14,986,793
| – | – | 0.65% | 28 |
|
|
2024
Q1 | $20.8M | Hold |
14,986,793
| – | – | 1.29% | 17 |
|
|
2023
Q4 | $12.6M | Hold |
14,986,793
| – | – | 0.84% | 23 |
|
|
2023
Q3 | $16.3M | Hold |
14,986,793
| – | – | 1.26% | 18 |
|
|
2023
Q2 | $29.1M | Buy |
14,986,793
+3,250,000
| +28% | +$6.31M | 2.22% | 14 |
|
|
2023
Q1 | $10.2M | Hold |
11,736,793
| – | – | 0.71% | 28 |
|
|
2022
Q4 | $11.7M | Buy |
11,736,793
+5,213,636
| +80% | +$5.18M | 0.65% | 27 |
|
|
2022
Q3 | $11.2M | Buy |
+6,523,157
| New | +$11.2M | 0.56% | 33 |
|
|
2020
Q2 | – | Sell |
-333,333
| Closed | -$3.33M | – | 47 |
|
|
2020
Q1 | $3.33M | Hold |
333,333
| – | – | 0.17% | 44 |
|
|
2019
Q4 | $3.57M | Hold |
333,333
| – | – | 0.17% | 40 |
|
|
2019
Q3 | $4.24M | Hold |
333,333
| – | – | 0.35% | 36 |
|
|
2019
Q2 | $5M | Hold |
333,333
| – | – | 0.35% | 33 |
|
|
2019
Q1 | $5.8M | Sell |
333,333
-1,666,667
| -83% | -$29M | 0.3% | 36 |
|
|
2018
Q4 | $4.64M | Hold |
2,000,000
| – | – | 0.18% | 37 |
|
|
2018
Q3 | $3.24M | Hold |
2,000,000
| – | – | 0.14% | 41 |
|
|
2018
Q2 | $7.26M | Hold |
2,000,000
| – | – | 0.34% | 36 |
|
|
2018
Q1 | $45.8M | Hold |
2,000,000
| – | – | 2.04% | 13 |
|
|
2017
Q4 | $25.5M | Buy |
+2,000,000
| New | +$25.5M | 1.06% | 22 |
|